-
HUMANISTIC AND ECONOMIC BURDEN OF METACHROMATIC LEUKODYSTROPHY ON PATIENTS, CAREGIVERS, AND HEALTHCARE SYSTEMS: FINDINGS FROM A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
REAL-WORLD TRENDS AND INTER-HOSPITAL VARIATION IN FIRST-LINE TREATMENT AND TIME TO NEXT TREATMENT IN METASTATIC NSCLC
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY OF ONCE-WEEKLY ICOSEMA VERSUS BASAL INSULINS, FIXED-RATIO COMBINATIONS, PREMIX INSULINS AND CO-FORMULATIONS IN INSULIN-NAïVE ADULTS WITH TYPE 2 DIABETES: A BAYESIAN NETWORK META-ANALYSIS
Aug 11, 2026, 17:15 PM -
ESTIMATING THE PREVALENCE OF UNCONTROLLED AND RESISTANT HYPERTENSION IN THE US: A STEPWISE PATIENT FUNNEL APPROACH USING OPTUM'S MARKET CLARITY DATASET
Aug 11, 2026, 17:15 PM -
REAL-WORLD CLINICAL AND ECONOMIC OUTCOMES OF THERAPIES FOR TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINESE PATIENTS: A RETROSPECTIVE ANALYSIS
Aug 11, 2026, 17:15 PM -
FROM DEFICIT RISK TO SURPLUS STRENGTH: A REVENUE-CENTERED ANALYSIS OF TURKIYE'S GENERAL HEALTH INSURANCE UTILIZING SOCIAL SECURITY INSTITUTION (SGK) DATA (2022-2025)
Aug 11, 2026, 17:15 PM -
MENOPAUSE AS A BEHAVIOURAL AND PSYCHOLOGICAL INFLECTION POINT IN OBESITY: UNDERSTANDING REAL-WORLD HETEROGENEITY AND LIVED EXPERIENCES
Aug 11, 2026, 17:15 PM -
THE HEALTH IMPACT OF PEMBROLIZUMAB AS FIRST-LINE (1L) TREATMENT FOR RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC) IN TURKIYE
Aug 11, 2026, 17:15 PM -
A COMMON MODELING FRAMEWORK FOR ONCOLOGY COST-EFFECTIVENESS ANALYSES ACROSS THREE DIFFERENT CANCER TYPES
Aug 11, 2026, 17:15 PM -
LIFESTYLE OR DISEASE? HOW EU HTA BODIES FRAME OBESITY AND THE CONSEQUENCES FOR REIMBURSEMENT OF ANTI-OBESITY MEDICINES
Aug 11, 2026, 17:15 PM -
PRICE ANALYSIS OF ONCOLOGY BIOLOGICS AND BIOSIMILARS IN SAUDI ARABIA: A CROSS-SECTIONAL STUDY (2015-2025)
Aug 11, 2026, 17:15 PM -
LONGITUDINAL EXUDATE BURDEN AND DELAYED HEALING IN VENOUS LEG ULCERS: A REAL-WORLD ELECTRONIC HEALTH RECORD ANALYSIS
Aug 11, 2026, 17:15 PM -
STRUCTURED ONCOLOGY LITERATURE SCREENING AS THE METHODOLOGICAL FOUNDATION FOR EU JOINT CLINICAL ASSESSMENT PREPARATION AND TARGET TRIAL EMULATION PLANNING
Aug 11, 2026, 17:15 PM -
HOW NATIONAL HTA SYSTEMS ARE BEING RESHAPED IN RESPONSE TO EU HTA: A REVIEW OF CURRENT REFORMS AND EARLY IMPLEMENTATION
Aug 11, 2026, 17:15 PM -
LONG-TERM REAL-WORLD PATIENT-REPORTED OUTCOMES AND URGENCY ON ADALIMUMAB IN ULCERATIVE COLITIS: 36-MONTH TRAJECTORIES FROM THE AMPERSAND DIGITAL COHORT
Aug 11, 2026, 17:15 PM -
PHARMACOECONOMIC EVALUATION OF A DIFFERENTIATED DRUG SCREENING PROGRAM IN ALGERIA: A COST-CONSEQUENCE ANALYSISPHARMACOECONOMIC EVALUATION OF A DIFFERENTIATED DRUG SCREENING PROGRAM IN ALGERIA: A COST-CONSEQUENCE ANALYSIS
Aug 11, 2026, 17:15 PM -
BENCHMARKING AS A TOOL FOR ASSESSING CROSS-COUNTRY COMPARABILITY OF SURVIVAL EVIDENCE FOR HTA
Aug 11, 2026, 17:15 PM -
HOW HAVE PRICES ACROSS THERAPY AREAS AND COUNTRIES EVOLVED OVER THE LAST 5 YEARS AND WHAT IMPACT CAN WE EXPECT PRICE REFERENCING POLICIES SUCH AS MFN TO HAVE IN THE FUTURE?
Aug 11, 2026, 17:15 PM -
BUDGET IMPACT ANALYSIS OF SOUVENAID FOR THE MANAGEMENT OF ALZHEIMER'S DISEASE IN MIDDLE EAST AND NORTH AFRICA REGION
Aug 11, 2026, 17:15 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH NON-SURGICAL AND POST-SURGICAL HYPOPARATHYROIDISM: A REAL-WORLD CLAIMS ANALYSIS
Aug 11, 2026, 17:15 PM
